Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

957.50INR
11 Aug 2020
Change (% chg)

Rs-0.45 (-0.05%)
Prev Close
Rs957.95
Open
Rs964.70
Day's High
Rs969.55
Day's Low
Rs945.00
Volume
6,023,045
Avg. Vol
3,914,239
52-wk High
Rs999.40
52-wk Low
Rs504.75

Select another date:

Wed, Aug 5 2020

India's Lupin to sell generic COVID-19 drug favipiravir

BENGALURU Lupin Ltd on Wednesday became the latest Indian drugmaker to launch a version of the antiviral drug favipiravir to treat COVID-19 in the world's third most affected country.

India's Lupin to sell generic COVID-19 drug favipiravir

BENGALURU Lupin Ltd on Wednesday became the latest Indian drugmaker to launch a version of the antiviral drug favipiravir to treat COVID-19 in the world's third most affected country.

India's Lupin to sell generic COVID-19 drug favipiravir

BENGALURU, Aug 5 Lupin Ltd on Wednesday became the latest Indian drugmaker to launch a version of the antiviral drug favipiravir to treat COVID-19 in the world's third most affected country.

BRIEF-Lupin Voluntarily Recalls Metformin Hydrochloride Extended-Release Tablets In U.S.

* VOLUNTARILY RECALLS ITS METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS IN U.S.

BRIEF-Lupin Ltd Says Got Approval For Its Albendazole Tablets From U.S. FDA

* LUPIN LTD SAYS LUPIN RECEIVES APPROVAL FOR ALBENDAZOLE TABLETS USP

BRIEF-Lupin Ltd Gets Orphan Drug Status For Mexiletine From U.S. FDA

* U.S. FDA GRANTS MEXILETINE ORPHAN DRUG DESIGNATION Further company coverage:

BRIEF-Lupin Says U.S. FDA Grants Mexiletine Orphan Drug Designation

* U.S. FDA GRANTS MEXILETINE ORPHAN DRUG DESIGNATION Source text for Eikon: Further company coverage:

BRIEF-Mylan And Lupin Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept

* MYLAN AND LUPIN RECEIVE EUROPEAN MARKETING AUTHORIZATION FOR NEPEXTO®, BIOSIMILAR ETANERCEPT Source text for Eikon: Further company coverage:

BRIEF-Lupin And Mylan Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept

* LUPIN AND MYLAN RECEIVE EUROPEAN MARKETING AUTHORIZATION FOR NEPEXTO, BIOSIMILAR ETANERCEPT Source text for Eikon: Further company coverage:

BRIEF-Lupin- Signs Distribution Agreement In Key EU Territories For Orphan Drug Namuscla

* LUPIN LTD - LUPIN SIGNS DISTRIBUTION AGREEMENT IN KEY EU TERRITORIES FOR ORPHAN DRUG NAMUSCLA Source text for Eikon: Further company coverage:

Select another date: